0.01
—
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Adheris Health
Its shares trade on ASX under the ticker AHE.AX. It has been listed since 26 May 2011. In the fiscal year to 30 June 2026, it reported revenue of A$34.0m and a net loss of A$20.0m. At that date it held total assets of A$16.6m and shareholders' equity of −A$2.4m.
Adheris Health Ltd is a AU-based company operating in Health Care Technology industry. Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 26 May 2011
- Website
- medadvisor.com.au ↗
Leadership
Pay as last reported
- Ms. Catherine HillInterim Chairman of the Board, since 2023
- Mr. Richard RatliffChief Executive Officer, Managing Director, Director, since 2022
- Mr. Sean SlatteryChief Financial Officer, Executive Director, since 2025
- Ms. Ruba El AfifiChief Operating Officer, since 2021A$403,237
- Mr. James RotsartExecutive Vice President US, Client Relations
- Mr. Craig SchnurigerActing Chief Technology Officer
- Mr. Wayne MarinoffExecutive General Manager ANZ – Sales & Marketing
- Mr. Josh SwinnertonChief Product Officer, since 2015A$224,119
- Ms. Gillian NairnCompany Secretary
- Mr. Kevin HutchinsonNon-Executive Director
- Mr. Lucas MerrowNon-Executive DirectorA$152,156
- Mr. Jim XenosNon-Executive DirectorA$49,275
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Adheris Health Ltd operates in the Health Care Technology industry with a focus on pharmacy-driven patient engagement solutions.
- The company utilizes THRiV, a cloud-based AI-enabled platform that analyzes data points to anticipate patient needs.
- THRiV provides personalized strategies and manages medication information in real time for patients and pharmacies.
Weaknesses
- The company's website is described as medadvisor.com.au, which may not reflect the current branding after rebranding.
- The source description treats the company as untrusted, indicating potential reliability issues with the provided information.
- The company's historical data, such as IPO date, may not be fully reflected in current operations.
Opportunities
- The company can expand its use of AI technology to enhance patient engagement solutions further.
- There is potential to leverage THRiV's data analysis capabilities for broader healthcare applications.
- Growth opportunities exist in the health care technology sector, especially with increasing demand for digital health solutions.
Threats
- The company faces competition from other health care technology providers in the market.
- Reliance on AI technology may pose risks if the technology fails or is not adopted widely.
- The untrusted source description may affect the company's reputation and investor confidence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.